Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 1001 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,7 |
| 1002 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 11,7 |
| 1003 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,2 |
| 1004 | Cord Tissue | Allogeneic – Related | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Romania | 3 |
| 1005 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,1 |
| 1006 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
| 1007 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,7 |
| 1008 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
| 1009 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 47,1 |
| 1010 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 22,11 |
| 1011 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 49,1 |
| 1012 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 54,6 |
| 1013 | Cord Tissue | Allogeneic – Unrelated | Muscular Dystrophy | Neurology | 2022 | Experimental Therapy | Poland | 62,9 |
| 1014 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
| 1015 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 1,4 |
| 1016 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 25,7 |
| 1017 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 14,1 |
| 1018 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 26,1 |
| 1019 | Cord Tissue | Allogeneic – Unrelated | Ovarian Dysfunction | Gynecology | 2022 | Experimental Therapy | Poland | 37,11 |
| 1020 | Cord Tissue | Allogeneic – Unrelated | Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer | Gynecology | 2022 | Experimental Therapy | Poland | 45,2 |
| 1021 | Cord Tissue | Allogeneic – Unrelated | Sclerosis Multiplex | Neurology | 2022 | Experimental Therapy | Poland | 41,3 |
| 1022 | Cord Tissue | Allogeneic – Unrelated | Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 23,9 |
| 1023 | Cord Tissue | Allogeneic – Unrelated | Spasmic Paralysis Of The Limbs | Neurology | 2022 | Experimental Therapy | Poland | 33,9 |
| 1024 | Cord Tissue | Allogeneic – Unrelated | Spastic Limb Paralysis | Neurology | 2022 | Experimental Therapy | Poland | 30,11 |
| 1025 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 12,11 |
| 1026 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 20 |
| 1027 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 39,11 |
| 1028 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2022 | Experimental Therapy | Poland | 35,6 |
| 1029 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
| 1030 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1031 | Cord Blood | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 2,5 |
| 1032 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 1033 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Hungary | 13 |
| 1034 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 8,8 |
| 1035 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Romania | 5 |
| 1036 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | UK | 11 |
| 1037 | Cord Blood | Allogeneic – Related | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Turkey | 19 |
| 1038 | Cord Blood | Autologous | Hydrocephalus | Neurology | 2022 | Experimental Therapy | Romania | 6 |
| 1039 | Cord Blood | Allogeneic – Related | Sickle Cell Anemia | Hematology | 2022 | Standard Therapy | Turkey | 7,7 |
| 1040 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2022 | Standard Therapy | Turkey | 19,2 |
| 1041 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1042 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1043 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1044 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1045 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1046 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 79 |
| 1047 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 1048 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1049 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 1050 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 1051 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1052 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1053 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1054 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 1055 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 1056 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1057 | Bone Marrow Family | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 1058 | Bone Marrow Family | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 1059 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1060 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 1061 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Type 2 | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1062 | Bone Marrow Family | Allogeneic | Leukocyte Adhesion Deficiency | Hematology | 2022 | Standard Therapy | Poland | 33 |
| 1063 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1064 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 1065 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 1066 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 1067 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 1068 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 1069 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 1070 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1071 | Bone Marrow Family | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1072 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1073 | Bone Marrow Family | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 1074 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1075 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1076 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1077 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1078 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1079 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1080 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1081 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1082 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
| 1083 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1084 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1085 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1086 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1087 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 1088 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1089 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1090 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
| 1091 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1092 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1093 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1094 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1095 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1096 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1097 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1098 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1099 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1100 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |